Clinical Oncology
Volume 18, Issue 9 , Pages 669-677, November 2006

Clinicopathological Review of 61 Patients with Early Bile Duct Cancer

  • J.M. Cha

      Affiliations

    • Department of Internal Medicine, East–West Neo Medical Center, University of Kyunghee College of Medicine, Seoul, Republic of Korea
  • ,
  • M.H. Kim

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    • Corresponding Author InformationAuthor for correspondence: Myung-Hwan Kim, PhD, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-dong, Songpa-gu, Seoul 138-736, Republic of Korea. Tel: +82-2-3010-3180.
  • ,
  • S.K. Lee

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • ,
  • D.W. Seo

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • ,
  • S.S. Lee

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • ,
  • J.H. Lee

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • ,
  • S.G. Lee

      Affiliations

    • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • ,
  • S.J. Jang

      Affiliations

    • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Received 12 March 2006; received in revised form 19 June 2006; accepted 3 July 2006.

Abstract 

Aims

The concept of early cancer is already established in the hollow viscus. However, there is no broadly accepted concept of early bile duct cancer. We aimed to assess whether early bile duct cancer patients have characteristic clinicopathological features and a better prognosis compared with patients with advanced bile duct cancer.

Materials and methods

Between June 1996 and December 2004, 614 patients were histologically confirmed with primary bile duct cancers after resection. Extrahepatic early bile duct cancers are defined as carcinoma where invasion is confined within the fibromuscular layer of the extrahepatic bile duct. Intrahepatic early bile duct cancers arising from intrahepatic large bile ducts are also defined as carcinoma confined within the fibromuscular layer. We retrospectively reviewed medical records to obtain demographic, laboratory, radiological and pathological data.

Results

Sixty-one (10%) patients were categorised with early bile duct cancers. They were frequently detected at asymptomatic (39%) or non-icteric (84%) stages. The most common gross type was the intraductal-growing type (58%). Not otherwise specified adenocarcinoma was only 67%, whereas papillary carcinoma was 31% of cancers. No lymph node metastasis and no lymphovascular/perineural invasions were noted in 89% of patients. The 5-year survival rate for early bile duct cancer was excellent (80%).

Conclusions

Although early bile duct cancer is not a common disease, it is not a very rare entity either. The clinicopathological features of early bile duct cancer patients differ from those of advanced bile duct cancer patients, with asymptomatic clinical presentation, different macroscopic and microscopic findings, and excellent prognosis.

Key words: Cholangiocarcinoma, early cancer, prognosis, survival

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0936-6555(06)00231-7

doi:10.1016/j.clon.2006.07.005

Clinical Oncology
Volume 18, Issue 9 , Pages 669-677, November 2006